Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


08.05.2017

20 AIDS
4 AIDS Res Hum Retroviruses
1 Am J Epidemiol
7 J Acquir Immune Defic Syndr
1 J Immunol
5 J Infect Dis
1 J Med Virol
1 J Virol
1 JAMA
3 Lancet HIV
2 PLoS Med
16 PLoS One
3 PLoS Pathog
1 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. KIM CJ, Rousseau R, Huibner S, Kovacs C, et al
    Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers: a randomized controlled trial.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001515.
    PubMed     Text format     Abstract available

  2. COBAN H, Robertson K, Smurzynski M, Krishnan S, et al
    Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV+ individuals on their first suppressive regimen.
    AIDS. 2017 May 3. doi: 10.1097/QAD.0000000000001523.
    PubMed     Text format     Abstract available

  3. CREPAZ N, Dong B, Chen M, Hall I, et al
    Examination of HIV infection through heterosexual contact with partners who are known to be HIV infected in the United States, 2010-2015.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001526.
    PubMed     Text format     Abstract available

  4. GUNST JD, Tolstrup M, Sogaard OS
    Beyond antiretroviral therapy: Early interventions to control HIV-1 infection.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001524.
    PubMed     Text format    

  5. TRIPLETTE M, Sigel KM, Morris A, Shahrir S, et al
    Emphysema and soluble CD14 are associated with pulmonary nodules in HIV-infected patients: Implications for lung cancer screening.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001529.
    PubMed     Text format     Abstract available

  6. LAL L, Audsley J, Murphy D, Fairley CK, et al
    Medication adherence, condom use and sexually transmitted infections in Australian PrEP users: interim results from the Victorian PrEP Demonstration Project.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001519.
    PubMed     Text format     Abstract available

  7. LONG LC, Maskew M, Brennan AT, Mongwenyana C, et al
    Initiating antiretroviral therapy for HIV at a patient's first clinic visit: A cost-effectiveness analysis of the RapIT randomized controlled trial.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001528.
    PubMed     Text format     Abstract available

  8. HOORNENBORG E, Achterbergh RCA, Schim Van Der Loeff MF, Davidovich U, et al
    Men who have sex with men starting pre-exposure prophylaxis (PrEP) are at risk of HCV infection: evidence from the Amsterdam PrEP study.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001522.
    PubMed     Text format     Abstract available

  9. ONOYA D, Sineke T, Brennan A, Long L, et al
    Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001517.
    PubMed     Text format     Abstract available

  10. ANDERSON DJ, Politch JA, Zeitlin L, Hiatt A, et al
    Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001521.
    PubMed     Text format     Abstract available

  11. SHANAUBE K, Schaap A, Floyd S, Phiri M, et al
    What works-reaching universal hiv testing: lessons from HPTN 071 (PopART) trial in Zambia.
    AIDS. 2017 May 3. doi: 10.1097/QAD.0000000000001514.
    PubMed     Text format     Abstract available

  12. LAGATHU C, Cossarizza A, Bereziat V, Nasi M, et al
    Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers.
    AIDS. 2017;31 Suppl 2:S105-S119.
    PubMed     Text format     Abstract available

  13. SABIN CA, Reiss P
    Epidemiology of ageing with HIV: what can we learn from cohorts?
    AIDS. 2017;31 Suppl 2:S121-S128.
    PubMed     Text format     Abstract available

  14. DALLA PRIA A, Merchant S, Bower M
    Oncological challenges for an ageing population living with HIV.
    AIDS. 2017;31 Suppl 2:S185-S189.
    PubMed     Text format     Abstract available

  15. SMITH JM, Flexner C
    The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development.
    AIDS. 2017;31 Suppl 2:S173-S184.
    PubMed     Text format     Abstract available

  16. NIGHTINGALE S, Winston A
    Measuring and managing cognitive impairment in HIV.
    AIDS. 2017;31 Suppl 2:S165-S172.
    PubMed     Text format     Abstract available

  17. BOCCARA F
    Cardiovascular health in an aging HIV population.
    AIDS. 2017;31 Suppl 2:S157-S163.
    PubMed     Text format     Abstract available

  18. GUARALDI G, Lonardo A, Maia L, Palella FJ Jr, et al
    Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver.
    AIDS. 2017;31 Suppl 2:S147-S156.
    PubMed     Text format     Abstract available

  19. HAWKINS KL, Brown TT, Margolick JB, Erlandson KM, et al
    Geriatric syndromes: new frontiers in HIV and sarcopenia.
    AIDS. 2017;31 Suppl 2:S137-S146.
    PubMed     Text format     Abstract available

  20. GUARALDI G, Palella FJ Jr
    Clinical implications of aging with HIV infection: perspectives and the future medical care agenda.
    AIDS. 2017;31 Suppl 2:S129-S135.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  21. QIAO YC, Xu Q, Wei JC, Ling W, et al
    Detection of HIV in Urine of HIV-infected patients without antiviral therapies.
    AIDS Res Hum Retroviruses. 2017 May 2. doi: 10.1089/AID.2017.0017.
    PubMed     Text format     Abstract available

  22. KOCHER M, McDermott M, Lindsey R, Shikuma C, et al
    HIV Patient Systemic Mitochondrial Respiration Improves with Exercise.
    AIDS Res Hum Retroviruses. 2017 May 3. doi: 10.1089/AID.2016.0287.
    PubMed     Text format     Abstract available

  23. LIFSON A, Workneh S, Shenie T, Ayana DA, et al
    Frequent Use of Khat, an Amphetamine-Like Substance: Association with Loss to Follow-up and Adherence Among Patients New to HIV Care in Ethiopia.
    AIDS Res Hum Retroviruses. 2017 May 2. doi: 10.1089/AID.2016.0274.
    PubMed     Text format     Abstract available

  24. GHIAM MK, Rebeiro P, Turner M, Rogers WB, et al
    Trends in HIV Continuum of Care Outcomes over 10 years of follow-up at a large HIV Primary Medical Home in the Southeastern United States.
    AIDS Res Hum Retroviruses. 2017 May 2. doi: 10.1089/AID.2017.0016.
    PubMed     Text format     Abstract available


    Am J Epidemiol

  25. LOKKEN EM, Balkus JE, Kiarie J, Hughes JP, et al
    Recent bacterial vaginosis is associated with acquisition of Mycoplasma genitalium.
    Am J Epidemiol. 2017 May 3. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  26. O'NEILL TJ, Djiometio Nguemo J, Tynan AM, Burchell AN, et al
    Risk Of Colorectal Cancer And Associated Mortality In Hiv: A Systematic Review And Meta-Analysis.
    J Acquir Immune Defic Syndr. 2017 May 1. doi: 10.1097/QAI.0000000000001433.
    PubMed     Text format     Abstract available

  27. SACDALAN C, Crowell TA, Colby DJ, Kroon E, et al
    Brief Report: Safety of frequent blood sampling in research participants in an acute HIV infection cohort in Thailand.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001436.
    PubMed     Text format     Abstract available

  28. POWELL AM, DeVita JM, Ogburu-Ogbonnaya A, Peterson A, et al
    The effect of HIV-centered obstetric care on perinatal outcomes among a cohort of women living with HIV.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001432.
    PubMed     Text format     Abstract available

  29. MAHEU-GIROUX M, Vesga JF, Diabate S, Alary M, et al
    Changing dynamics of HIV transmission in Cote d'Ivoire: modeling who acquired and transmitted infections and estimating the impact of past HIV interventions (1976-2015).
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001434.
    PubMed     Text format     Abstract available

  30. FOGEL JM, Piwowar-Manning E, Debevec B, Walsky T, et al
    Impact of early antiretroviral therapy on the performance of HIV rapid tests and HIV incidence assays.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001421.
    PubMed     Text format     Abstract available

  31. HOFFMANN CJ, Mabuto T, Ginindza S, Fielding KL, et al
    Strategies to Accelerate HIV Care and Antiretroviral Therapy Initiation Following HIV Diagnosis: a Randomized Trial.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001428.
    PubMed     Text format     Abstract available

  32. GONSALVES GS, Paltiel AD, Cleary PD, Gill MJ, et al
    A Flow-Based Model of the HIV Care Continuum in the United States.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001429.
    PubMed     Text format     Abstract available


    J Immunol

  33. KELLER B, Stumpf I, Strohmeier V, Usadel S, et al
    High SYK Expression Drives Constitutive Activation of CD21low B Cells.
    J Immunol. 2017 May 3. pii: 1700079. doi: 10.4049/jimmunol.1700079.
    PubMed     Text format     Abstract available


    J Infect Dis

  34. CELUM C, Hong T, Cent A, Donnell D, et al
    Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.
    J Infect Dis. 2017;215:907-910.
    PubMed     Text format     Abstract available

  35. MARGOT NA, Wong P, Kulkarni R, White K, et al
    Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment-Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide.
    J Infect Dis. 2017;215:920-927.
    PubMed     Text format     Abstract available

  36. ERLANDSON KM, Wu K, Koletar SL, Kalayjian RC, et al
    Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy.
    J Infect Dis. 2017;215:933-937.
    PubMed     Text format     Abstract available

  37. KHOURY G, Fromentin R, Solomon A, Hartogensis W, et al
    Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
    J Infect Dis. 2017;215:911-919.
    PubMed     Text format     Abstract available

  38. UPRETY P, Lindsey JC, Levin MJ, Rainwater-Lovett K, et al
    Inflammation and Immune Activation in Antiretroviral-Treated Human Immunodeficiency Virus Type 1-Infected African Infants and Rotavirus Vaccine Responses.
    J Infect Dis. 2017;215:928-932.
    PubMed     Text format     Abstract available


    J Med Virol

  39. BLACKARD JT, Ma G, Welge JA, Taylor LE, et al
    Cytokine/chemokine expression associated with Human Pegivirus (HPgV) infection in women with HIV.
    J Med Virol. 2017 Apr 29. doi: 10.1002/jmv.24836.
    PubMed     Text format     Abstract available


    J Virol

  40. BURANAPRADITKUN S, Pissani F, Teigler JE, Schultz BT, et al
    Preservation of peripheral T follicular helper cell function in HIV controllers.
    J Virol. 2017 May 3. pii: JVI.00497-17. doi: 10.1128/JVI.00497.
    PubMed     Text format     Abstract available


    JAMA

  41. HAMPTON T
    Cell Marker May Help Identify Latent HIV Reservoirs.
    JAMA. 2017;317:1715.
    PubMed     Text format    


    Lancet HIV

  42. THE LANCET HIV
    The role of testing in HIV prevention.
    Lancet HIV. 2017;4:e189.
    PubMed     Text format    


  43. Correction.
    Lancet HIV. 2017 Apr 27. pii: S2352-3018(17)30085.
    PubMed     Text format    

  44. THE LANCET HIV
    Doubts hang over PEPFAR finances.
    Lancet HIV. 2017;4:e189.
    PubMed     Text format    


    PLoS Med

  45. IWUJI C, Newell ML
    Towards control of the global HIV epidemic: Addressing the middle-90 challenge in the UNAIDS 90-90-90 target.
    PLoS Med. 2017;14:e1002293.
    PubMed     Text format     Abstract available

  46. HAYES R, Floyd S, Schaap A, Shanaube K, et al
    A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
    PLoS Med. 2017;14:e1002292.
    PubMed     Text format     Abstract available


    PLoS One

  47. CHANDRA D, Gupta A, Leader JK, Fitzpatrick M, et al
    Assessment of coronary artery calcium by chest CT compared with EKG-gated cardiac CT in the multicenter AIDS cohort study.
    PLoS One. 2017;12:e0176557.
    PubMed     Text format     Abstract available

  48. HUBER F, Merceron A, Madec Y, Gadio G, et al
    High mortality among male HIV-infected patients after prison release: ART is not enough after incarceration with HIV.
    PLoS One. 2017;12:e0175740.
    PubMed     Text format     Abstract available

  49. ASHABA S, Kaida A, Coleman JN, Burns BF, et al
    Psychosocial challenges facing women living with HIV during the perinatal period in rural Uganda.
    PLoS One. 2017;12:e0176256.
    PubMed     Text format     Abstract available

  50. AL-AMOUDI SM, Al-Harbi AA, Al-Sayegh NY, Eldeek BS, et al
    Health rights knowledge among medical school students at King Abdulaziz University, Jeddah, Saudi Arabia.
    PLoS One. 2017;12:e0176714.
    PubMed     Text format     Abstract available

  51. KOIRALA S, Deuba K, Nampaisan O, Marrone G, et al
    Facilitators and barriers for retention in HIV care between testing and treatment in Asia-A study in Bangladesh, Indonesia, Lao, Nepal, Pakistan, Philippines and Vietnam.
    PLoS One. 2017;12:e0176914.
    PubMed     Text format     Abstract available

  52. ABUDULAI LN, Fernandez S, Corscadden K, Burrows SA, et al
    Production of IgG antibodies to pneumococcal polysaccharides is associated with expansion of ICOS+ circulating memory T follicular-helper cells which is impaired by HIV infection.
    PLoS One. 2017;12:e0176641.
    PubMed     Text format     Abstract available

  53. MANION M, Hullsiek KH, Wilson EMP, Rhame F, et al
    Vitamin D deficiency is associated with IL-6 levels and monocyte activation in HIV-infected persons.
    PLoS One. 2017;12:e0175517.
    PubMed     Text format     Abstract available

  54. FERRIAN S, Manca C, Lubbe S, Conradie F, et al
    A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis.
    PLoS One. 2017;12:e0176660.
    PubMed     Text format     Abstract available

  55. PREBENSEN C, Troseid M, Ueland T, Dahm A, et al
    Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial.
    PLoS One. 2017;12:e0176527.
    PubMed     Text format     Abstract available

  56. MOQUEET N, Kanagaratham C, Gill MJ, Hull M, et al
    A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection.
    PLoS One. 2017;12:e0176282.
    PubMed     Text format     Abstract available

  57. FRIAS M, Rivero-Juarez A, Tellez F, Perez-Perez M, et al
    Spontaneous clearance of chronic hepatitis C is rare in HIV-infected patients after effective use of combination antiretroviral therapy.
    PLoS One. 2017;12:e0177141.
    PubMed     Text format     Abstract available

  58. HAYASHIDA T, Tsuchiya K, Kikuchi Y, Oka S, et al
    Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors.
    PLoS One. 2017;12:e0177033.
    PubMed     Text format     Abstract available

  59. CURTIS KA, Hanson DL, Price KA, Owen SM, et al
    Performance characteristics of an antibody-based multiplex kit for determining recent HIV-1 infection.
    PLoS One. 2017;12:e0176593.
    PubMed     Text format     Abstract available

  60. EDELMAN EJ, So-Armah K, Cheng DM, Doyle MF, et al
    Impact of illicit opioid use on T cell subsets among HIV-infected adults.
    PLoS One. 2017;12:e0176617.
    PubMed     Text format     Abstract available

  61. GADOEV J, Asadov D, Harries AD, Parpieva N, et al
    Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan.
    PLoS One. 2017;12:e0176473.
    PubMed     Text format     Abstract available

  62. KWAA AK, Goldsborough K, Walker-Sperling VE, Pianowski LF, et al
    The effect of Ingenol-B on the suppressive capacity of elite suppressor HIV-specific CD8+ T cells.
    PLoS One. 2017;12:e0174516.
    PubMed     Text format     Abstract available


    PLoS Pathog

  63. BRANDENBERG OF, Magnus C, Rusert P, Gunthard HF, et al
    Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.
    PLoS Pathog. 2017;13:e1006313.
    PubMed     Text format     Abstract available

  64. FENNESSEY CM, Pinkevych M, Immonen TT, Reynaldi A, et al
    Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy.
    PLoS Pathog. 2017;13:e1006359.
    PubMed     Text format     Abstract available

  65. SERRANO-VILLAR S, Sainz T, Ma ZM, Utay NS, et al
    Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naive to Antiretroviral Therapy: A Pilot Randomized Trial.
    PLoS Pathog. 2017;13:e1006368.
    PubMed     Text format     Abstract available


    Vaccine

  66. HU D, Bowder D, Wei W, Thompson J, et al
    Tryptophan 375 stabilizes the outer-domain core of gp120 for HIV vaccine immunogen design.
    Vaccine. 2017 Apr 28. pii: S0264-410X(17)30546.
    PubMed     Text format     Abstract available


    Virology

  67. MEADOR LR, Kessans SA, Kilbourne J, Kibler KV, et al
    A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.
    Virology. 2017;507:242-256.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: